Renal denervation and blood pressure reduction in resistant hypertension: A systematic review and meta-analysis

Open Heart

Volumn 1, Issue 1, 2014, Pages

  Kwok, Chun Shing ^a   Loke, Yoon K ^b   Pradhan, Shiva ^c   Keavney, Bernard ^a   El Omar, Magdi ^d   Mamas, Mamas A ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CATHETER BASED RENAL SYMPATHETIC DENERVATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DEATH; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEART INFARCTION; HUMAN; KIDNEY DENERVATION; KIDNEY DISEASE; META ANALYSIS; NEW ONSET RENAL DISEASE; OBSERVATIONAL STUDY; PATIENT SAFETY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; SYMPATHETIC NERVE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 84984653695     PISSN: None     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2014-000092     Document Type: Article

References (28)

1. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. 2009.
2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
3. Calhoun DA, Jones D, Textor S, et al. American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51:1403-19.
4. Schlaich M, Sobotka P, Krum H, et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009;54:1195-201.
5. Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet 2010;376:1878-80.
6. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275-81.
7. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9.
8. Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rational and design of the SYMPLICITY HTN-3 trial. Clin Cardiol 2012;35:528-35.
9. Bhatt DL, Kandzari DE, O'Neill WW, et al. SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-401.
10. Higgins JPT, Deeks JJ, Altman DG. Chapter 9: analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons, 2008.
11. Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 2007;176:1091-6.
12. Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 2012;60:1163-70.
13. Franzen KF, Mortensen K, Himmel F, et al. Percutaneous renal denervation improves central hemodynamics and arterial stiffness - a pilot study. ESC Congress; Vol 33, Munchen, Germany 2012:771.
14. Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012;59:901-9.
15. Brandt MC, Reda S, Mahfoud F, et al. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol 2012;60:1956-65.
16. Fatum C, Gisbertz C, Himmel F, et al. Effect of renal denervation therapy on sodium excretion in patients with resistant hypertension. ESC Congress; Vol 33, Munchen, Germany, 2012:182.
17. Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension. Circulation 2011;123:1940-6.
18. Mahfoud F, Cremers B, Janker J, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 2012;60:419-24.
19. Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 2011;58:1176-82.
20. Lambert GW, Hering D, Esler MD, et al. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension 2012;60:1479-84.
21. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911-17.
22. Howard JP, Nowbar AN, Francis DP. Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4121 patients with focus on trial design: the CONVERGE report. Heart 2013;99:1579-87.
23. Bilazarian S. Confession of a SYMPLICITY HTN-3 Trialist. Medscape, 2014.
24. Bakris G. The SYMPLICITY HTN-3 Co-PI gives his 2 cents. Medscape, 2014.
25. Messerli FH, Bangalore S. Renal denervation for resistant hypertension? N Engl J Med 2014;370:1454-7.
26. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9.
27. Uder A, Schmid A, Titze S, et al. Renal artery denervation for the treatment of hypertension: opening up new horizons. Cardiovasc Intervent Radiol 2011;34:442-4.
28. Mafeld S, Vasdev N, Haslam P. Renal denervation for treatment-resistant hypertension. Ther Adv Cardiovasc Dis 2012;6:245-58.